INDV Indivior Pharmaceuticals, Inc.: institutional ownership and insider trading
347 funds reported holding $5.17B of Indivior Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net sold $142M, with 83 new positions and 37 funds selling out; over the last 12 months insiders bought $312K and sold $2.83M on the open market.
Famous investors holding INDV
- Howard Marks (Oaktree Capital Management): $251M, 3.5% of the portfolio
- Izzy Englander (Millennium Management): $86.1M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $118M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $12.8M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $2.80M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $9.68M, 0.0% of the portfolio
Largest institutional holders of INDV
- BlackRock, Inc. (BLK) — $768M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $311M
- OAKTREE CAPITAL MANAGEMENT LP — $251M
- VANGUARD CAPITAL MANAGEMENT LLC — $225M
- STATE STREET CORP (STT, STT-PG) — $205M
- FULLER & THALER ASSET MANAGEMENT, INC. — $189M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $139M
- FRANKLIN RESOURCES INC (BEN) — $136M
- Two Seas Capital LP — $132M
- GEODE CAPITAL MANAGEMENT, LLC — $130M
Recent INDV insider trades
- Aug 27, 2026: Anderson Woodrow D bought 1,500 shares ($53.5K)
- Aug 5, 2026: Anderson Woodrow D bought 1,500 shares ($54.4K)
- Jul 10, 2026: Heidbreder Christian sold 18,586 shares ($765K)
- Jun 11, 2026: Heidbreder Christian sold 18,586 shares ($707K)
5%+ owners
- Vanguard Portfolio Management: 6.6% (Schedule 13G, filed Apr 28, 2026)
- Millennium Management LLC: 5.4% (Schedule 13G, filed Sep 30, 2026)
- Vanguard Capital Management: 5.4% (Schedule 13G, filed Apr 27, 2026)